Assuming they have amazing plans ahead after getting that approval, an uplist and therefore going to dollar land is definitely a long-term possibility.
That's the million dollar question! One can reasonably conclude though that this company has the potential to return to its previous highs over time (look at the 3 year chart) with such a promising future (assuming FDA approval). You can easily justify that potential because the market valued it there in the past (2-3 years ago). However, IMO, with approval and potential partnership interest as well as possible uplisting efforts (if successful) those high will be surpassed in time. And, the valuation of this company will only continue to grow if their road-map of additional products is delivered upon and accepted in the market.
I believe we could be trading in the $30 to $50 Dollar range and listed on NASDAQ. ADMD will go immediately into distribution and sales upon FDA Approval. No more waiting after the FDA gives the green light.
News 
Market Data 
Discover 
